The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ponomareva E.N.

FGBU "Federal'nyĭ nauchno-klinicheskiĭ tsentr" FMBA Rossii

Kazarian A.A.

Idiopathic epiretinal membrane: definition, classification, current understanding of pathogenesis

Authors:

Ponomareva E.N., Kazarian A.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2014;130(3): 72‑78

Read: 3859 times


To cite this article:

Ponomareva EN, Kazarian AA. Idiopathic epiretinal membrane: definition, classification, current understanding of pathogenesis. Russian Annals of Ophthalmology. 2014;130(3):72‑78. (In Russ.)

Recommended articles:

References:

  1. Johnson T., Johnson M. Epiretinal membrane. China: Elsevier Inc.; 2004.
  2. Patronas M., Kroll A., Lou P., Ryan E. A Review of Vitreoretinal Interface Pathology. Int. Ophthalmol. Clin. 2009; 49 (1): 133-143.
  3. Geller S., Lewis G., Fisher S. FGFR1, signaling, and AP-1 expression after retinal detachment: reactive Muller and RPE cells. Invest. Ophthalmol. Vis. Sci. 2001; 42: 1363-1369.
  4. Iwanoff A. Beitrage zur normalen und pathologischen Anatomie des Auges. Graefes Arch. Clin. Exp. Ophthalmol. 1865; 11: 135-170.
  5. Green W. Retinal and periretinal proliferations. Philadelphia: WB Saunders Company; 1996.
  6. Kampik A., Green W., Michels R. Ultrastructural features of progressive idiopathic epiretinal membranes removed by vitreous surgery. Am. J. Ophthalmol. 1980; 90: 797-809.
  7. McCarty D., Mukesh B., Chikani V., Wang J., Mitchell P., Taylor H., McCarty C. Prevalence and associations of epiretinal membranes in the visual impairment project. Am. J. Ophthalmol. 2005; 140: 288-294.
  8. Klein R., Klein B., Wang Q., Moss S. The epidemiology of epiretinal mambranes. Trans. Am. Ophthalmol. 1994; 92: 403-25.
  9. Gass J. Stereoscopic atlas of macular diseases: diagnosis and treatment. St. Louis: Mosby; 1997.
  10. Duan X., Liang Y., Friedman D., Sun L., Wei W., Wang J., Wang G., Liu W., Tao Q., Wang N., Wong T. Prevalence and associations of epiretinal membranes in a rural chinese adult population: The Handan Eye Study. Invest. Ophthalmol. Vis. Sci. 2009; 50 (5): 2018-2023.
  11. Sheard R., Sethi C., Gregor Z. Acute macular pucker. Ophthalmology. 2003; 110: 1178-1184.
  12. Miyazaki M., Nakamura H., Kubo M., Kiyohara Y., Iida M., Ishibashi T., Nosa Y. Prevalence and risk factors for epiretinal membranes in a japanese population: the Hisayama Study. Graefes Arch. Clin. Exp. Ophthalmol. 2003; 241 (8): 642-646.
  13. You Q., Xu L., Jonas J. Prevalence and associations of epiretinal membranes in adult chinese: the Beijing eye study. Eye. 2008; 22 (7): 874-879.
  14. Balashevich L.I., Baiborodov Ya.V, Dzhusoev T.M., Gatsu M.V., Valeeva R.R. Study of pathology features of vitreomacular interface at the rear hyaloid membrane separation based on the method of optical coherence tomography. Oftal'mokhirurgiya. 2006; 1: 24-28. (In Russ.)
  15. Roth A., Foos R. Surface wrinkling retinopathy in eye enucleated at autopsy. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1971; 75: 1047-1059.
  16. McDonald H., Johnson R., Ai E. Macular Epiretinal Membranes. Philadelphia: WB Saunders Company; 2006.
  17. Oberstein S., Byun J., Herrera D., Chapin E., Fisher S., Lewis G. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration. Mol. Vis. 2011; 17: 1794-1805.
  18. Theodorus P., Marja J., Roelofje J., Pas H., Hooymans J., Los L. Human retinal Müller cells synthesize collagens of the vitreous and vitreoretinal interface in vitro. Mol. Vis. 2008; 14: 652-660.
  19. Okada M., Ogino N., Matsumura M., Honda Y., Nagai Y. Histological and immunohistochemical study of idiopathic epiretinal membrane. Ophthalmic. Res. 1995; 27: 118-128.
  20. Reichenbach A., Germer A., Bringmann A., Biedermann B., Pannicke T., Francke M., Kuhrt H., Reichelt W., Mack A. Glio-neuronel interactions in retinal development. N.-Y.: Springer; 1998.
  21. Heidenkummer H., Kampik A., Petrovski B. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases. Retina. 1992; 12: 52-8.
  22. Machemer R. Massive periretinal proliferation: a logical approach to therapy. Trans. Am. Ophthalmol. 1977; 75: 556-586.
  23. Chung S., Lee J., Kang S., Kim Y., Lee S. Characteristics of epiretinal membranes according to the presence or absence of posterior vitreous detachment. Eye. 2011; 25 (10): 1341-1346.
  24. Vit V.V. Stroenie zritel'noi sistemy cheloveka [The structure of the human visual system]. Odessa: Astroprint Publ.; 2003.
  25. Gandorfer A., Schumann R., Scheler R., Haritoglou C., Kampik A. Pores of the inner limiting membrane in flat-mounted surgical specimens. Retina. 2011; 31 (5): 977-981.
  26. Kadonosono K., Itoh N., Nomura E., Ohno S. Perifoveal microcirculation in eyes with epiretinal membranes. Br. J. Ophthalmol. 1999; 83: 1329-1331.
  27. Yagi T, Sakata K., Funatsu H., Noma H., Yamamoto K., Hori S. Macular microcirculation in patients with epiretinal membrane before and after surgery. Graefes Arch. Clin. Exp. Ophthalmol. 2012; 250 (6): 931-934.
  28. Armstrong D., Augustin A., Spengler R., Al-Jada A., Nickola T., Grus F., Koch F. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica. 1998; 212: 410-414.
  29. Iannetti L., Accorinti M., Malagola R., Bozzoni-Pantaleoni F., Da Dalt S., Nicoletti F., Gradini R., Traficante A., Campanella M., Pivetti-Pezzi P. Role of the intravitreal growth factors in the pathogenesis of idiopathic epiretinal membrane. Invest. Ophthalmol. Vis. Sci. 2011; 52 (8): 5786-5789.
  30. Vinores S., Henderer J., Mahlow J., Chiu C., Derevjanik N., Larochelle W., Csaky C., Campochiaro P. Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. Exp. Eye Res. 1995; 60: 607-619.
  31. Chen Y., Hackett S., Schoenfeld C., Vinores M., Vinores S., Campochiaro P. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br. J. Ophthalmol. 1997; 81: 919-926.
  32. Takagi H., Koyama S., Seike H., Oh H., Otani A., Matsumura M., Honda Y. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 2003; 44: 393-402.
  33. Briggs M., Grierson I., Hiscott P., Hunt J.A. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. Invest. Ophthalmol. Vis. Sci. 2000; 41: 3085-3094.
  34. Harada C., Harada T., Mitamura Y., Quah H., Ohtsuka K., Kotake S., Ohno S., Wada K., Takeuchi S., Tanaka K. Diverse NF-kB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy. Mol. Vis. 2004; 10: 31-36.
  35. Mitamura Y., Okumura A., Harada C., Namekata K., Nakamura K., Tashimo A., Ohtsuka K., Harada T. Activator protein-1 in epiretinal membranes of patients with proliferative diabetic retiopathy. Diabetologia. 2006; 49 (1): 209-211.
  36. Storksen N., Harsh G., Gibbs V., Williams L. Regulated expression of the platelet-derived growth factor A chain gene in microvascular endothelial cells. J. Biol. Chem. 1987; 262: 14381-14384.
  37. Hogg P., Grierson I., Hiscott P. Direct comparison of the migration of three cell types involved in epiretinal membrane formation. Invest. Ophthalmol. Vis. Sci. 2002; 43: 2749-2757.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.